Back to News
Market Impact: 0.35

RGTI vs IONQ: Which Quantum Computing Stock Has More Upside Potential?

Source: zacks.com

Technology & InnovationCorporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst Insights
RGTI vs IONQ: Which Quantum Computing Stock Has More Upside Potential?

IonQ reported Q2 2026 revenue of $80.1 million, up 287% year over year, raised its 2026 revenue outlook to $280–$290 million and cited $485 million in remaining performance obligations; however, it recorded a $1.9 billion GAAP net loss, largely from a noncash warrant revaluation. Rigetti revenue rose 185% to $5.1 million and it held $541.3 million in cash with no debt, but its operating loss widened to $28.1 million and its potential $100 million Commerce Department funding is not finalized. Analyst price targets imply 137.5% upside for Rigetti and 99.6% for IonQ, while the article emphasizes IonQ’s stronger commercial traction and execution and profitability risks for both companies.

Analysis

The investable distinction is not growth rate but evidence of repeatable demand. Rigetti’s percentage growth is being measured from a very small base; system sales can make quarterly revenue and gross margin volatile. Its cash balance reduces near-term financing pressure, but does not validate the 1,000-qubit roadmap. The potential federal award is not bankable until definitive terms are disclosed, and equity consideration would weaken the “cash-funded runway” argument. HPE’s hybrid-computing work is strategically relevant, but should not be capitalized as near-term revenue without contract economics.

IonQ has better near-term revenue visibility, but backlog is not cash flow: conversion timing, cancellation terms, customer concentration and acquired SkyWater contribution need verification. Its spending and post-acquisition integration make revenue growth alone an inadequate scorecard. SkyWater may gain strategic utilization, but any benefit depends on actual production volumes and economics; do not assume quantum manufacturing demand offsets integration costs.

Over days, analyst target upside is not a catalyst and is especially weak evidence in a high-volatility, long-duration theme. Over 1–3 months, watch revenue guidance, RPO conversion and definitive funding terms. Over 6–18 months, system performance and manufacturing yield determine whether either company earns a durable premium. Contrarian point: the market may overvalue headline growth and qubit roadmaps while underweighting lumpy deployments, dilution and cash consumption. There is no clean valuation-based pair signal in the supplied data.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mixed

Sentiment Score

0.05

Ticker Sentiment

HPE0.15
IONQ0.35
RGTI0.25
SKYT0.20

Key Decisions for Investors

  • Do not trade the analyst-target upside comparison as a valuation signal. Obtain current enterprise values and cash-flow estimates before initiating a directional position.
  • Conditional relative-value watch: favor IONQ over RGTI only if its valuation premium is not already discounting sustained RPO conversion and improving unit economics; otherwise stay flat rather than shorting a volatile thematic name.
  • Use upcoming reports as triggers: reconsider IONQ if guidance or RPO conversion weakens, or integration costs rise without disclosed operating benefits; reconsider RGTI if commercial revenue broadens beyond episodic system sales and technical fidelity milestones are independently demonstrated.
  • Treat RGTI’s Commerce opportunity as an alert, not a funding assumption. Verify definitive award size, timing and consideration; equity issuance would dilute the thesis, while a signed non-dilutive award would improve its funding profile.
  • Falsification checks over 6–18 months: repeated customer deployments and improving cash economics would support IONQ; missed performance milestones or persistent weak commercial conversion would undermine RGTI’s roadmap case.

More News

From AllMind Research

Browse all research